Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme
Glioblastoma (GBM) is one of the most malignant and intractable central nervous system tumors with high recurrence, low survival rate, and poor prognosis. Despite the advances of aggressive, multimodal treatment, a successful treatment strategy is still elusive, often leading to therapeutic resistan...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academic Press Inc.
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |